Get the Stockscreener App
6.61
1.54%
0.10
After Hours:
6.45
-0.16
-2.42%
Champions Oncology Inc stock is traded at $6.61, with a volume of 3,547.
It is up +1.54% in the last 24 hours and down -3.22% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$6.51
Open:
$6.48
24h Volume:
3,547
Relative Volume:
0.11
Market Cap:
$91.14M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-9.3099
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
+1.07%
1M Performance:
-3.22%
6M Performance:
-16.33%
1Y Performance:
+51.26%
1-Day Range:
$6.293
$6.61
1-Week Range:
$6.293
$6.8907
52-Week Range:
$3.75
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.61 | 89.76M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Leading vs lagging indicators on Champions Oncology Inc. performancePortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Will Champions Oncology Inc. bounce back from current supportJuly 2025 Decliners & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-14 14:26:26 - newser.com
Relative strength of Champions Oncology Inc. in sector analysisJuly 2025 Setups & Expert Curated Trade Setups - newser.com
Patient Derived Xenograft Model Market Set to Significantly - openPR.com
Is Champions Oncology Inc. showing signs of accumulationJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Sentiment analysis tools applied to Champions Oncology Inc.2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-13 08:52:57 - newser.com
Will Champions Oncology Inc. continue its uptrendTrade Performance Summary & Long-Term Capital Growth Strategies - newser.com
Published on: 2025-10-13 07:32:41 - newser.com
Will Champions Oncology Inc. stock see insider buyingJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
What moving averages say about Champions Oncology Inc.July 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
How Champions Oncology Inc. (2I3) stock reacts to stronger dollarJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
3 Dividend Champion Stocks I'm Watching in 2025 - sharewise.com
Will Champions Oncology Inc. (2I3) stock benefit from sector leadershipJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
Will Champions Oncology Inc. (2I3) stock keep raising dividendsJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
How to interpret RSI for Champions Oncology Inc. stockWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Volatility clustering patterns for Champions Oncology Inc.Profit Target & Technical Pattern Based Signals - newser.com
Using RSI to spot recovery in Champions Oncology Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Why Champions Oncology Inc. (2I3) stock could rally stronglyEarnings Overview Report & Growth Focused Entry Point Reports - newser.com
Is Champions Oncology Inc. stock ready for breakout2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
Can Champions Oncology Inc. stock maintain operating marginsForecast Cut & AI Forecast Swing Trade Picks - newser.com
Visual analytics tools that track Champions Oncology Inc. performanceDividend Hike & Precise Entry and Exit Recommendations - newser.com
Best data tools to analyze Champions Oncology Inc. stockWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
Institutional scanner results for Champions Oncology Inc.Trade Volume Summary & Verified Chart Pattern Signals - newser.com
Is Champions Oncology Inc. a candidate for recovery playPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Why Champions Oncology Inc. stock appeals to analysts2025 Pullback Review & AI Driven Stock Reports - newser.com
What drives Champions Oncology Inc 2I3 stock priceSector ETF Performance & Double Or Triple Capital - earlytimes.in
Champions Oncology Inc Stock Analysis and ForecastStock Price Divergence & Free Phenomenal Investment Performance - earlytimes.in
Champions Oncology Inc 2I3 Stock Analysis and ForecastGlobal Trade Effects & Outstanding Investment Returns - earlytimes.in
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):